All lobbying filings

THEGROUP DC, LLC

THEGROUP DC, LLC filed a Q2 report for ASTELLAS PHARMA US, INC on July 20, 2026, reporting $70,000 in lobbying income.

Lobbying for ASTELLAS PHARMA US, INC · Pharmaceutical research and manufacturing company.

All filings by THEGROUP DC, LLC · Everything ASTELLAS PHARMA US, INC has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.

Pharmacy

H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.

Bills named in this filing 1

H. Res. 1090
Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month".

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.